thismeintiel said:
Roronaa_chan said: The Order seems to be performing nicely on all Amazons, 1 month away from release In US, both SKUs ahead of Evolve's single SKU. Standard 90-110, CE 160-180, Premium sold out months ago In UK, already #83 in yearly chart (there are 2 SKUs) In FR, already #43 in yearly chart (despite being split in 3 SKUs) In DE, already #64 in yearly chart (despite being split in 3 SKUs) Was already doing well in EU but the latest trailers really helped it start climbing in the US and UK charts. Just for curiosity's sake, it's ahead of Evolve in all of these amazons, despite being further away from release. Despite a beta built for hype, ads and plenty of awards, Evolve interest seems to be fairly modest. Either that or The Order's just doing better than one would imagine I'll be interested in seeing how things stand for Bloodborne in the same time frame (1 month before release)
|
I think Evole's lack of interest probably stems from them announcing how they are tackling DLC, and the prices that go along with it. I think people are just getting tired of DLC milking. Especially for small things like 6-7 new characters for $25.
|
And the fact that it just doesn't look all that interesting and the gaming media seems to have an agenda towards it.